Ginjaleling

Country of origin: Indonesia, P.T. Phytochemindo Rex Indonesia

Pharm-Group: Various antispasmodics of animal and plant origin

Manufacturers: Daria-Varia Laboratoria (Indonesia), P.T. Phytochemindo Rex (Indonesia)

International name: Ginjaleling

Dosage forms: capsules 500 mg, capsules

Ingredients: Each capsule contains: Orthosiphonis folium leaves, Strobilanthus folium leaves, Phyllanthi herba, Alang-alang rhizomes (Imperatae rhizoma)

Indications for use: Prevention and treatment of urolithiasis (when stones are localized no more than 0.3-0.4 cm in size (maximum 0.6 cm) in the renal pelvis, as well as for removing small stones from the upper urinary tract, including freeing the ureter from stone fragments after lithotripsy) as part of complex therapy.

Contraindications: Hypersensitivity to the components of the drug.

Side effect: No information.

Interaction: No information.

Overdose: No information.

Special instructions: During the course of treatment with Ginjaleling, it is recommended to increase the amount of fluid consumed.

Literature:

1. Instructions for use of the drug "Ginjaleling" were approved by the Pharmacological Committee of the Ministry of Health of the Russian Federation on October 09, 2003 and approved by the Department of State Control of Medicines and Medical Equipment of the Ministry of Health of the Russian Federation on November 18. 2003
2. Prospectus of the manufacturer.